The US-FDA (US- Food and Drugs Administration) announced on 13 August that it will permit the marketing of Natural Cycles’ contraception app in the US for pre-menopausal women aged 18 years and older.
The opening of a new Biomedical Blockchain Research Center was announced by the Icahn School of Medicine at Mount Sinai and the Institute for Next Generation Healthcare which aims to solve healthcare and medical science issues with new technologies and data.
The US Army is testing a telemedicine-based platform designed to send critical data from the field to the hospital and enabling providers to prepare for incoming patients. The connected care service is used by health systems and EMS providers for better care coordination during emergencies.
With a view of gathering mHealth data through a wearable from over 800 people with Parkinson’s disease, a project has been unveiled by the Michael J Fox Foundation which has been doing pioneering work in Parkinson’s disease.
A Fitbit official disclosed eight mobile health apps, including two focused on diabetes management and one on oncology care.
Researchers from the University of California San Diego have developed a low-cost, single-use tattoo-like wearable that measures the user’s glucose levels. According to a release from the institution, this noninvasive technology will be at the center of a newly announced pilot clinical trial designed to test the accuracy and acceptability of the tattoos.
The agency released a five-point plan outlining regulatory changes to bolster medical device safety, including requiring manufacturers ensure devices can be updated and patched.
The FDA today approved the first medical device to harness artificial intelligence for the detection of diabetic retinopathy in adults who have diabetes.
Health technology and clinical wearables are hot topics in the healthcare and pharmaceutical industries. They are creating waves of excitement and talking points for debate, while also topping many of the healthcare trends of this year.
Singapore-based DocDoc, an Asian patient empowerment company, announced on March 19 that it has raised US$5.45 million (RM21.33 million) in their Series B round of funding.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.